Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02912754
Title Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

chronic lymphocytic leukemia

Therapies

Ibrutinib

Ibrutinib + Ruxolitinib

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.